Tag: EARLY TAVR
SCAI 2025: Early TAVI “should be preferred to clinical surveillance in all age groups”
Analysis from the EARLY TAVR trial, presented at the 2025 Society for Cardiovascular Angiography &am...
Edwards’ Sapien 3 lands US FDA approval for the treatment of asymptomatic severe AS
Edwards Lifesciences has announced that the US Food and Drug Administration (FDA) has approved i...
TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis
EARLY TAVR lived up to its billing as one of the most hotly anticipated trials to be presented a...
